Riyaz Bashir

[Giuseppe Biondi-Zoccai @gbiondizoccai]

Balloon Pulmonary Angioplasty for Treatment of Chronic Thromboembolic Pulmonary Hypertension: Statement From the BPA-CTEPH Alliance https://t.co/eZr53mw0R6

[Temple Cardiology Fellowship @TempleCards]

We had a blast at I ♥️ @Phillies Heart & Vascular night celebrating our @TempleHealth #PulmonaryHypertension patient throwing the first ⚾️ pitch in excellent health! 🩺

Sorry @RedSox … it was a “W” for “PH” x 2️⃣❣️

🏆💚🔔🫀

[Cat Jennings @bsc_vascular]

Big News! The 544th—and final—patient has been enrolled in #HIPEITHO, a landmark RCT comparing EKOS + anticoagulation vs. anticoagulation alone in intermediate-high risk #PE. Thank you to our investigators, @PERTConsortium & @UnimedizinMainz. Learn more: https://t.co/u5SkH7GUiS

[Amy Goldberg @AJGTempleSurg]

@RiyazBashir and his team continue to make incredible strides with their research. This latest development could lead to major advancements in treating acute pulmonary embolism. Proud of their innovation and dedication to making a real difference in the lives of patients.

[Akhilesh Sista @akhileshsistaMD]

2 landmark VTE trials ECLIPSED major milestones on this auspicious day! Congrats @moiz_hafiz and the SIU team for enrolling PE-TRACT participant number 100, on the same day that C-TRACT enrolled number 200. @PERTConsortium @SIRspecialists @WCMRadiology @VMJ_SVM @NATFthrombosis

[Kashif Chaudhry @KashifMD]

To anyone who wrongly conflates Israel’s occupation with the Jewish people, know that hundreds of thousands of Israeli Jews oppose the occupation of Palestine & call for peaceful coexistence.

There is no excuse for antisemitism in any shape or form. ✡️❤️☪️

[Sunil V. Rao @SVRaoMD]

@DrChuckSimonton Important trial!

[TODAY @TODAYshow]

20 years ago, NBC journalist David Bloom passed away from a pulmonary embolism while embedded with American troops in Iraq. His widow Melanie joins TODAY to talk about her 20-year mission to raise awareness about blood clots. She is joined by @GBarnesMD to discuss risk factors.

[Thrombolex Inc. @ThrombolexInc]

Join Thrombolex today @ VEINS 2023 and discover how the BASHIR™ Family of Endovascular Catheters safely and effectively treats A+VTE. Learn more at https://t.co/qqejtgx4Cy.

#VEINSConference #Thrombolex

[Thrombolex Inc. @ThrombolexInc]

Attending VEINS 2023? Join us for an informative industry-sponsored break session 10/29 discussing the future of PM-CDT treatment for PE and Venous Disease, featuring Dr. Eric Secemsky. Register for VEINS 2023: https://t.co/KRFLAfpDsS
https://t.co/qqejtgx4Cy #Thrombolex

[Yevgeniy Brailovsky DO MSc FACC @YevgeniyBr]

Please see our accompanying editorial where we highlight important innovations in catheter-based therapies of PE and suggest future directions for outcome measures in interventional PE trials https://t.co/CwPkVzruie @vakasullah @PERTConsortium

[Robert A Lookstein MD, MHCDL @roblookstein]

New publication from the RESCUE trial for #PE Effect of Pharmacomechanical Catheter-Directed Thrombolysis on Segment... https://t.co/vQTW2iDQKu

[Robert A Lookstein MD, MHCDL @roblookstein]

Another meta-analysis? @PERTConsortium Catheter-directed thrombolysis compared with systemic thrombolysis and anticoagulation in patients with intermediate- or high-risk pulmonary embolism: systematic review and network meta-analysis https://t.co/EccXZnF88I

[Riyaz Bashir @RiyazBashir]

@pravinp8 @MeiliZach @ASE360 @TempleIM @TempleHealth @scratchedrecord @tiffchenMD @MartinGKeaneMD @SabrinaIslamMD @AkhilNarangMD Congratulations Zack and Pravin

[Riyaz Bashir @RiyazBashir]

Here are the components of the SCAD score.

[Muhammad Umar Khalid @umarkhalidmd]

First SCAD risk assessment score for patients presenting with MI. Thanks for the guidance @RiyazBashir @VladLakhter and congrats to the team. #SCAD #myocardialinfarction #CardioTwitter #MedTwitter https://t.co/JsxzAoD9PB

[Pravin Patil @pravinp8]

Graduating Interventional Fellow Grand Rounds with our @TempleCards alum @AadharM @TempleGME @TempleHealth

Congrats Aadhar!

[Riyaz Bashir @RiyazBashir]

FDA approves endovascular catheter for the treatment of acute pulmonary embolism https://t.co/uaZXJT0XOL

[Temple Health News @TempleMedNews]

The Bashir Endovascular Catheter, invented @templemedschool and developed @ThrombolexTM, has been approved by the @US_FDA for treatment of acute pulmonary embolism. Dr. @RiyazBashir, of @TempleHealth, is a co-inventor. Read more about the news here: https://t.co/0iubCXRFR5

[UCLA Gastroenterology and Hepatology @UCLAGIHep]

🏆 Kudos @MatthewYZhao! @AmerGastroAssn Abstract Award for Health Disparities Research at #DDW2023

Colorectal Cancer Rates at FQHC in the US from 2020 to 2021: Incomplete Rebound & Worsening Disparities

#MayLabUCLA: Yvonne Lei @meganrmcleod @jbadmph @DrGaloosianMD @drfolamay

[Riyaz Bashir @RiyazBashir]

@NHLBI_LUNGDir I thank NHLBI and the lung division for supporting the RESCUE trial. The RESCUE trial data led to FDA clearance, which will benefit patients with acute PE and DVT around the globe.